Marketing-authorisation holder · Taiwan
新加坡商雪蘭諾股份有限公司台灣分公司
1 medicine in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
1 medicine
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| REBIF 22 MICROGRAMS注射劑 | Interferon beta-1a | Taiwan | Cancelled | 1999 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Taiwan | 1 | 0 | 1 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Taiwan Food and Drug Administration
TFDA, dataset 9122, Government Open Data Licence 1.0; source update and retrieval dates